Form S-1 Jupiter Neurosciences Inc For: 26 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jupiter Neurosciences Inc (JUNS)
Jupiter Neurosciences Inc stock price live, this page displays NASDAQ JUNS stock exchange data. View the JUNS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jupiter Neurosciences Inc real time stock price chart below.
What Is the Jupiter Neurosciences Inc Stock Price Today?
The Jupiter Neurosciences Inc stock price today is 0.22.
What Is the Stock Symbol for Jupiter Neurosciences Inc?
The stock symbol for Jupiter Neurosciences Inc is "JUNS."
What Stock Exchange Does Jupiter Neurosciences Inc Trade On?
Jupiter Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Jupiter Neurosciences Inc a Good Stock to Buy?
Determining whether Jupiter Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUNS quote. (ISIN: US48208B2034)
What Is the Jupiter Neurosciences Inc Stock Price Today?
The Jupiter Neurosciences Inc stock price today is 0.22.
What Is the Stock Symbol for Jupiter Neurosciences Inc?
The stock symbol for Jupiter Neurosciences Inc is "JUNS."
What Stock Exchange Does Jupiter Neurosciences Inc Trade On?
Jupiter Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Jupiter Neurosciences Inc a Good Stock to Buy?
Determining whether Jupiter Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUNS quote. (ISIN: US48208B2034)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.21
0.23
52 wk Range
0.17
3.33
Unusual Post-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.210.23
52 wk Range
0.173.33
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
JUNS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
30.00
Upside
+13,536.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form PRE 14A Jupiter Neurosciences Inc For: 9 June
- Investing.com
- Form 8K Jupiter Neurosciences Inc For: 22 June
- Investing.com
- Form S-1 Jupiter Neurosciences Inc For: 26 June
- Investing.com
- Form 8K Jupiter Neurosciences Inc For: 22 June
- Investing.com
- Form DEF 14A Jupiter Neurosciences Inc For: 22 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 30.00
(+13,536.36% Upside)
Earnings
Latest Release
May 14, 2026
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
18.65K / 225K
Compare JUNS to Peers and Sector
Metrics to compare | JUNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJUNSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −1.1x | −0.4x | |
PEG Ratio | 0.01 | −0.20 | 0.00 | |
Price/Book | −3.4x | 2.3x | 2.6x | |
Price / LTM Sales | 236.2x | 2.4x | 3.0x | |
Upside (Analyst Target) | - | 107.1% | 50.7% | |
Fair Value Upside | Unlock | 2.4% | 6.5% | Unlock |
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson’s disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alzheimer’s disease; JNS102, which is in Phase II clinical trial for the treatment of mucopolysaccharidosis type 1; and JNS107, which is in Phase II clinical trial for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. It is also involved in the commercialization and sale of GLO for skin beauty, MND for mental clarity, and PWR for energy, endurance, and muscle recovery under the Nugevia brand name. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Jupiter Neurosciences (JUNS) Stock Price Today?
The Jupiter Neurosciences stock price today is 0.22 USD.
What Stock Exchange Does Jupiter Neurosciences Trade On?
Jupiter Neurosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Jupiter Neurosciences?
The stock symbol for Jupiter Neurosciences is "JUNS."
What Is the Jupiter Neurosciences Market Cap?
As of today, Jupiter Neurosciences market cap is 9.68M USD.
What Is Jupiter Neurosciences's Earnings Per Share (TTM)?
The Jupiter Neurosciences EPS (TTM) is -0.26.
When Is the Next Jupiter Neurosciences Earnings Date?
Jupiter Neurosciences will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is JUNS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jupiter Neurosciences Stock Split?
Jupiter Neurosciences has split 0 times.
How Many Employees Does Jupiter Neurosciences Have?
Jupiter Neurosciences has 5 employees.
What is the current trading status of Jupiter Neurosciences (JUNS)?
As of Jul 03, 2026, Jupiter Neurosciences (JUNS) is trading at a price of 0.22 USD, with a previous close of 0.22 USD. The stock has fluctuated within a day range of 0.21 USD to 0.23 USD, while its 52-week range spans from 0.17 USD to 3.33 USD.
What Is Jupiter Neurosciences (JUNS) Price Target According to Analysts?
The average 12-month price target for Jupiter Neurosciences is 30.00 USD, with a high estimate of 30 USD and a low estimate of 30 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +13,536.36% Upside potential.
What Is the JUNS After Hours Price?
JUNS's last after hours stock price is 0.21 USD, the stock has decreased by -0.01, or -5.83%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.